Skip to main content

Table 5 Propensity to discuss each dimension by region

From: Identifying important breast cancer control strategies in Asia, Latin America and the Middle East/North Africa

  Asia
N = 97
Latin Am
N = 46
ME/NA
N = 39
Aus/Can
N = 39
p value
Building capacity (%)      
   Science and research 51.5 50.0 56.4 46.2 0.84
   Skilled nurses 50.5 41.3 51.3 38.5 0.48
   Research infrastructure 29.9a 58.7b 30.8a, b 41.0a, b 0.01
   National statistics 26.8a 37.0a, b 51.3a, b 56.4b 0.003
   Public education 42.3 47.8 46.2 33.3 0.56
Developing evidence (%)      
   Study of local etiology 23.7 37.0 28.2 33.3 0.38
   Personalized therapy 36.1a 82.6b 20.5a 48.7a < 0.001
   Developing guidelines 23.7a 47.8b 12.8a 51.3b < 0.001
   International networks 52.6a, b 63.0b 30.8a 66.7b 0.01
   Local communication 36.1a 34.8a 10.3b 56.4a < 0.001
Removing barriers (%)      
   Out-of-pocket costs 38.1a, b 47.8b 10.3c 20.5a, c < 0.001
   Disparities in access 37.1a, c 69.6b 23.1a 53.8b, c < 0.001
   High cost to payers 42.3 56.5 38.5 53.8 0.22
   Early detection 45.4 50.0 46.2 41.0 0.88
   Reimbursement 43.3a, b 45.7a, b 28.2b 61.5a 0.03
Promoting advocacy (%)      
   Patient empowerment 26.8a 39.1a, b 23.1a, b 53.8b 0.008
   Managing survivorship 12.4a 17.4a 0.0b 33.3a 0.004
   Quality of life 19.6 28.3 20.5 33.3 0.31
   Metastatic disease 36.1 26.1 33.3 28.2 0.63
   Organized advocacy 13.4a, c 43.5b 28.2c 5.1a < 0.001
  1. Based on the Mariscuillo multiple comparisons procedure [21, 22], common superscripts a, b, c reflect paired comparisons that are not statistically different, while pairs that are statistically different do not share the same superscript.